BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
KRChoksey Research Report
Supriya Lifescience Ltd., established in 2008, is one of the leading manufacturers and suppliers of active pharmaceuticals ingredients globally. The company caters through its niche product offerings of 38 APIs with focus on diverse therapeutic segments. It is a leader in therapeutic segments like anti-histamines, anti-allergic, anti-asthmatics, anesthetic and vitamins.
We recently visited Supriya Lifescience’s manufacturing plant at Lote, Chiplun in Maharashtra. During our visit we got an opportunity to meet the management of the company.
We believe Supriya Lifescience is well placed with its leadership position in niche products and its backward integrated facilities with geographical diversification which should help uphold the momentum in the coming years.
Also with that, its continuous focus towards penetrating into regulated markets and its APIs finding newer applications in various therapeutic areas should augur well for the company.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
As a Subscriber you get
Stories
RECOMMENDED FOR YOU
POPULAR